Tens of millions of people face sticker shock enrolling in Affordable Care Act insurance for 2026. To save money, the Trump administration wants them to consider less generous coverage.
Born from personal experience and backed by scientific excellence, MYmAb Biologics is leading a quiet revolution in cancer research—anchored in Malaysia, aiming for the world.